Cargando…

Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery

PURPOSE: To evaluate the effects of diquafosol sodium ophthalmic solution 3% (DQS) and artificial tears (AT) on higher-order aberrations (HOAs) in patients with dry eye after cataract surgery. DESIGN: This was a post hoc analysis of a previously conducted randomized clinical study. METHODS: Fifty-ni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Yasushi, Ochi, Shintarou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207435/ https://www.ncbi.nlm.nih.gov/pubmed/28096651 http://dx.doi.org/10.2147/OPTH.S122542

Ejemplares similares

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
por: Takamura, Etsuko, et al.
Publicado: (2012)

Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano, Shiro, et al.
Publicado: (2017)

Short-term application of diquafosol ophthalmic solution benefits children with dry eye wearing orthokeratology lens
por: Yang, Yuanfang, et al.
Publicado: (2023)

Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution
por: Ishikawa, Sho, et al.
Publicado: (2023)

Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis
por: Wang, Tianjiao, et al.
Publicado: (2023)

3% diquafosol sodium eye drops in Chinese patients with dry eye: a phase IV study
por: Wang, Wenying, et al.
Publicado: (2023)

Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery
por: Yamazaki, Kenichiro, et al.
Publicado: (2022)

Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
por: Nagahara, Yukiko, et al.
Publicado: (2015)

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease
por: Mun, Yongseok, et al.
Publicado: (2018)

The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study
por: Chen, Jiayan, et al.
Publicado: (2023)

Correction: The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study
por: Chen, Jiayan, et al.
Publicado: (2023)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

Higher-Order Aberrations in Myopic Eyes
por: Karimian, Farid, et al.
Publicado: (2010)

Effect of Cyclosporine 0.09% Treatment on Accuracy of Preoperative Biometry and Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
por: Hovanesian, John A, et al.
Publicado: (2021)

Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study
por: Miyake, Kensaku, et al.
Publicado: (2017)

Effect of Diquafosol Ophthalmic Solution on Airflow-Induced Ocular Surface Disorder in Diabetic Rats
por: Dota, Atsuyoshi, et al.
Publicado: (2020)

Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
por: So, Ha Rim, et al.
Publicado: (2023)

Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study
por: Hori, Yuichi, et al.
Publicado: (2022)

Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery
por: Lee, Jang Hoon, et al.
Publicado: (2016)

Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial
por: Jun, Ikhyun, et al.
Publicado: (2019)

Lipid conformational order and the etiology of cataract and dry eye
por: Borchman, Douglas
Publicado: (2021)

Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials
por: Zhao, Xinyu, et al.
Publicado: (2017)

Correlation between higher-order aberration and photophobia after cataract surgery
por: Ishiguro, Naoko, et al.
Publicado: (2022)

Characteristics and influencing factors of corneal higher-order aberrations in patients with cataract
por: Zhou, Suowang, et al.
Publicado: (2023)

Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial
por: Miura, Maria, et al.
Publicado: (2022)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
por: Miyake, Hideki, et al.
Publicado: (2016)

Protocol for a parallel assignment prospective, randomised, comparative trial to evaluate the safety and efficacy of intense pulsed light (IPL) combined with 3% diquafosol (DQS) ophthalmic solution in dry eye syndrome
por: Chen, Jiayan, et al.
Publicado: (2023)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2019)

Upper Eyelid Meibomian Gland Dysfunction is a Risk Factor for Dry Eye Symptoms Following Cataract Surgery in the Early Phase
por: Fujimoto, Hisataka, et al.
Publicado: (2022)

Association between Corneal Higher-Order Aberrations Evaluated with a Videokeratographer and Corneal Surface Abnormalities in Dry Eye
por: Kusada, Natsuki, et al.
Publicado: (2023)

Monochromatic higher order aberrations in highly myopic eyes with Staphyloma
por: Delgado-Tirado, Santiago, et al.
Publicado: (2021)

Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials
por: Liu, Shuang, et al.
Publicado: (2023)

Diquafosol ophthalmic solution enhances mucin expression via ERK activation in human conjunctival epithelial cells with hyperosmotic stress
por: Lee, Hyun Jung, et al.
Publicado: (2022)

A Systematic Review on the Association Between Tear Film Metrics and Higher Order Aberrations in Dry Eye Disease and Treatment
por: Rhee, Jess, et al.
Publicado: (2021)

Safety and efficacy of pilocarpine, cevimeline, and diquafosol compared to artificial tears for the treatment of dry eye: protocol for a systematic review
por: Serrano-Robles, José Gerardo, et al.
Publicado: (2022)

Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2020)

Topography and Higher Order Corneal Aberrations of the Fellow Eye in Unilateral Keratoconus
por: Aksoy, Sibel, et al.
Publicado: (2017)

Topography and Higher Order Corneal Aberrations of the Fellow Eye in Unilateral Keratoconus
por: Koç, Mustafa, et al.
Publicado: (2018)

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
por: Shrivastava, Saurabh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0408e0nggs5r38tht88hoe3in9